Tharimmune, Inc.: Tharimmune Announces 1-for-15 Reverse Stoc

BRIDGEWATER, NJ / ACCESSWIRE / May 22, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in

Related Keywords

Tirtht Patel , , Nasdaq , Omniab Inc , Exchange Commission , Company Board Of Directors , Tharimmune Inc , Nasdaq Capital Market , Annual Meeting , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Ihr Portfolio ,